Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory...
Main Authors: | Stephen W. Mamber, Steven Krakowka, Jeffrey Osborn, Lloyd Saberski, Ryan G. Rhodes, Albert E. Dahlberg, Sunthorn Pond-Tor, Kara Fitzgerald, Neal Wright, Sarah Beseme, John McMichael |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2020-06-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mSphere.00288-20 |
Similar Items
-
Thimerosal Dalam Vaksin, Suatu Tinjauan Pustaka
by: Lina Herliana Soemara
Published: (2016-12-01) -
Toxicological effects of thimerosal on rat kidney: a histological and biochemical study
by: M. U. Ijaz, et al.
Published: (2021-08-01) -
Effect of thimerosal on thyroid hormones metabolism in rats
by: Thiago U Pantaleão, et al.
Published: (2017-11-01) -
A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs
by: David A. Geier, et al.
Published: (2019-04-01) -
Microbiota Modulates the Immunomodulatory Effects of Filifolinone on Atlantic Salmon
by: Mick Parra, et al.
Published: (2020-08-01)